Remdesivir is authorized under Food & Drug Administration (FDA) Emergency Use Authorization (EUA) for treatment of COVID-19. In accordance with Texas Health and Safety Code Sec. 161.00705, recording administration of Antiviral, Immunization and other Medication for disasters and emergencies must be entered in the Texas Immunization Registry, ImmTrac2.
Currently, Remdesivir can only be reported online in ImmTrac2. For additional information please visit our website at www.ImmunizeTexas.org.
Have specific ordering questions? Please contact the Vulnerable Populations and Facilities Task Force (VPFTF) at VPFTF@dshs.texas.gov.
Remdesivir Fact Sheet for Health Care Providers: www.fda.gov/media/137566/download
Remdesivir Fact Sheet for Patients and Parent/Caregivers: